Altamira Therapeutics reports successful outcomes for Bentrio nasal spray in NASAR clinical trial

Altamira Therapeutics Ltd. (Nasdaq:CYTO), a leading innovator in RNA delivery technology for non-liver targets, has achieved significant milestones in its recent NASAR clinical trial for ... Read More